elubirixin   Click here for help

GtoPdb Ligand ID: 8499

Synonyms: SB 656933 | SB-656933 | SB656933
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Elubirixin (SB-656933) is reported as a CXCR2 selective antagonist [1-2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 4
Rotatable bonds 6
Topological polar surface area 119.15
Molecular weight 462.03
XLogP 3.26
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES O=C(Nc1cccc(c1Cl)F)Nc1ccc(c(c1O)S(=O)(=O)N1CCNCC1)Cl
Isomeric SMILES O=C(Nc1cccc(c1Cl)F)Nc1ccc(c(c1O)S(=O)(=O)N1CCNCC1)Cl
InChI InChI=1S/C17H17Cl2FN4O4S/c18-10-4-5-13(23-17(26)22-12-3-1-2-11(20)14(12)19)15(25)16(10)29(27,28)24-8-6-21-7-9-24/h1-5,21,25H,6-9H2,(H2,22,23,26)
No information available.
Summary of Clinical Use Click here for help
SB-656933 was evaluated in Phase 2 clinical trial aiming to reduce neutrophil-mediated airway inflammation in cystic fibrosis patients (NCT00903201 [3]), and Phase 1 for chronic obstructive pulmonary disease (COPD; ). A Phase 2 study in ulcerative colitis patiients (NCT00748410) was terminated.